Milos Dokmanovic
- Molecular Biology top 2%
- Oncology top 2%
- Physiology top 10%
- Immunology top 10%
- Cancer Research top 10%
- Co-authors
- Paul A. MarksWen Jin WuLang NgoIgor B. RoninsonNishant MohanBey-Dih ChangDianne S. HirschYi Shen
- Topics
- HER2/EGFR in Cancer Research (9 papers)Monoclonal and Polyclonal Antibodies Research (7 papers)Histone Deacetylase Inhibitors Research (6 papers)
- Cited by
- Molecular BiologyOncologyPhysiology
- Partner nations
- United StatesSwedenIsrael
In The Last Decade
Milos Dokmanovic
26 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Molecular Biology 2.9k
- Oncology 1.1k
- Physiology 305
- Immunology 248
- Cancer Research 228
Countries citing papers authored by Milos Dokmanovic
This map shows the geographic impact of Milos Dokmanovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Milos Dokmanovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Milos Dokmanovic more than expected).
Fields of papers citing papers by Milos Dokmanovic
This network shows the impact of papers produced by Milos Dokmanovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Milos Dokmanovic. The network helps show where Milos Dokmanovic may publish in the future.
Co-authorship network of co-authors of Milos Dokmanovic
This figure shows the co-authorship network connecting the top 25 collaborators of Milos Dokmanovic. A scholar is included among the top collaborators of Milos Dokmanovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Milos Dokmanovic. Milos Dokmanovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 18 | |
| 3 | 24 | |
| 4 | 52 | |
| 5 | 14 | |
| 6 | 46 | |
| 7 | 16 | |
| 8 | 106 | |
| 9 | 10 | |
| 10 | 21 | |
| 11 | 84 | |
| 12 | Histone Deacetylase Inhibitors: Overview and Perspectivesbreakdown → | 931 |
| 13 | 234 | |
| 14 | 157 | |
| 15 | 263 | |
| 16 | 405 | |
| 17 | Growth inhibitory targets of retinoids. | 1 |
| 18 | 34 | |
| 19 | 58 | |
| 20 | A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. | 459 |
About Milos Dokmanovic
Milos Dokmanovic is a scholar working on Oncology, Immunology and Allergy and Radiology, Nuclear Medicine and Imaging, having authored 27 papers that have together received 3.6k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (9 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Histone Deacetylase Inhibitors Research (6 papers). The work is most often cited by research in Molecular Biology (2.9k citations), Oncology (1.1k citations) and Physiology (84 citations). Milos Dokmanovic has collaborated with scholars based in United States, Sweden and Israel. Frequent co-authors include Paul A. Marks, Wen Jin Wu, Lang Ngo, Igor B. Roninson, Nishant Mohan, Bey-Dih Chang, Dianne S. Hirsch, Yi Shen, Yongzhi Xuan and Eugene Kandel. Their work appears in journals such as Proceedings of the National Academy of Sciences, Genes & Development and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.